All data are based on the daily closing price as of February 16, 2026
a

ASKA Pharmaceutical Holdings

4886.TSE
16.47 USD
0.82
+5.24%

Overview

Last close
16.47 usd
Market cap
467.59M usd
52 week high
17.48 usd
52 week low
11.96 usd
Target price
16.3 usd

Valuation

P/E
12.1536
Forward P/E
N/A
Price/Sales
1.0437
Price/Book Value
0.9927
Enterprise Value
491.51M usd
EV/Revenue
1.1246
EV/EBITDA
9.0079

Key financials

Revenue TTM
437.07M usd
Gross Profit TTM
211.39M usd
EBITDA TTM
47.30M usd
Earnings per Share
1.1 usd
Dividend
0.2 usd
Total assets
719.62M usd
Net debt
51.26M usd

About

ASKA Pharmaceutical Holdings Co.,Ltd., through its subsidiaries, engages in the pharmaceutical, animal health, and other businesses in Japan. The company researches, develops, manufactures, and markets pharmaceutical products in the areas of endocrinology, obstetrics and gynecology, and urology; and researches, manufactures, imports, exports, and sells veterinary medicines, veterinary medical devices, feed and feed additives, reagents, agrochemicals, industrial chemicals, hygiene products, and food products and their raw materials. It is also involved in the clinical examination and biological testing activities; and offers quasi-drugs, food supplements, and medical devices. The company was founded in 1920 and is headquartered in Tokyo, Japan.
  • Symbol
    4886.TSE
  • Exchange
    TSE
  • Isin
    JP3119660003
  • Country
    Japan
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - Specialty & Generic
  • CEO
  • Headquarter
    Tokyo
  • Web site
    https://www.aska-pharma-hd.co.jp
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top